143 related articles for article (PubMed ID: 38465940)
1. Adjusting Incidence Estimates with Laboratory Test Performances: A Pragmatic Maximum Likelihood Estimation-Based Approach.
Weng Y; Tian L; Boothroyd D; Lee J; Zhang K; Lu D; Lindan CP; Bollyky J; Huang B; Rutherford GW; Maldonado Y; Desai M;
Epidemiology; 2024 May; 35(3):295-307. PubMed ID: 38465940
[TBL] [Abstract][Full Text] [Related]
2. Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches.
Bouman JA; Riou J; Bonhoeffer S; Regoes RR
PLoS Comput Biol; 2021 Feb; 17(2):e1008728. PubMed ID: 33635863
[TBL] [Abstract][Full Text] [Related]
3. Antibody tests for identification of current and past infection with SARS-CoV-2.
Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
[TBL] [Abstract][Full Text] [Related]
4. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
[TBL] [Abstract][Full Text] [Related]
5. Association of protective behaviors with SARS-CoV-2 infection: results from a longitudinal cohort study of adults in the San Francisco Bay Area.
Judson TJ; Zhang S; Lindan CP; Boothroyd D; Grumbach K; Bollyky JB; Sample HA; Huang B; Desai M; Gonzales R; Maldonado Y; Rutherford G;
Ann Epidemiol; 2023 Oct; 86():1-7. PubMed ID: 37524216
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Design of a population-based longitudinal cohort study of SARS-CoV-2 incidence and prevalence among adults in the San Francisco Bay Area.
Lindan CP; Desai M; Boothroyd D; Judson T; Bollyky J; Sample H; Weng Y; Cheng Y; Dahlen A; Hedlin H; Grumbach K; Henne J; Garcia S; Gonzales R; Craik CS; Rutherford G; Maldonado Y
Ann Epidemiol; 2022 Mar; 67():81-100. PubMed ID: 34800659
[TBL] [Abstract][Full Text] [Related]
8. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
9. Estimation of SARS-CoV-2 Seroprevalence in Central North Carolina: Accounting for Outcome Misclassification in Complex Sample Designs.
Vias NP; Cassidy CA; Edwards JK; Xiong K; Beatty Parker C; Aiello AE; Boyce RM; Shook-Sa BE
Epidemiology; 2023 Sep; 34(5):721-731. PubMed ID: 37527450
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
11. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
Stevenson M; Metry A; Messenger M
Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
[TBL] [Abstract][Full Text] [Related]
12. Collaborative double robust targeted maximum likelihood estimation.
van der Laan MJ; Gruber S
Int J Biostat; 2010 May; 6(1):Article 17. PubMed ID: 20628637
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Panel Data Modeling and Surveillance of COVID-19 in Metropolitan Areas in the United States: Longitudinal Trend Analysis.
Oehmke TB; Post LA; Moss CB; Issa TZ; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Feb; 23(2):e26081. PubMed ID: 33481757
[TBL] [Abstract][Full Text] [Related]
14. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
[TBL] [Abstract][Full Text] [Related]
15. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
[TBL] [Abstract][Full Text] [Related]
16. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
[TBL] [Abstract][Full Text] [Related]
17. An EM algorithm for nonparametric estimation of the cumulative incidence function from repeated imperfect test results.
Witte BI; Berkhof J; Jonker MA
Stat Med; 2017 Sep; 36(21):3412-3421. PubMed ID: 28631295
[TBL] [Abstract][Full Text] [Related]
18. Data-driven prediction of COVID-19 cases in Germany for decision making.
Refisch L; Lorenz F; Riedlinger T; Taubenböck H; Fischer M; Grabenhenrich L; Wolkewitz M; Binder H; Kreutz C
BMC Med Res Methodol; 2022 Apr; 22(1):116. PubMed ID: 35443607
[TBL] [Abstract][Full Text] [Related]
19. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
Westgate PM
Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
[TBL] [Abstract][Full Text] [Related]
20. The risk of over-diagnosis in serological testing. Implications for communications strategies.
Biggeri A; Forni S; Braga M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):184-192. PubMed ID: 33412809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
